nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A3—prostate cancer	0.0893	0.215	CbGaD
Desipramine—CYP2C18—prostate cancer	0.0784	0.189	CbGaD
Desipramine—SLC22A1—prostate cancer	0.064	0.154	CbGaD
Desipramine—CYP2A6—prostate cancer	0.05	0.12	CbGaD
Desipramine—ADRB2—prostate cancer	0.0408	0.0983	CbGaD
Desipramine—ORM1—Abiraterone—prostate cancer	0.039	0.117	CbGbCtD
Desipramine—CYP2E1—prostate cancer	0.0355	0.0854	CbGaD
Desipramine—CYP2C19—prostate cancer	0.0352	0.0846	CbGaD
Desipramine—SLC22A3—Estradiol—prostate cancer	0.0226	0.0677	CbGbCtD
Desipramine—CYP3A4—prostate cancer	0.0224	0.0538	CbGaD
Desipramine—SLC22A2—Estradiol—prostate cancer	0.0134	0.04	CbGbCtD
Desipramine—CYP2C19—Nilutamide—prostate cancer	0.0129	0.0384	CbGbCtD
Desipramine—CYP2C19—Bicalutamide—prostate cancer	0.0129	0.0384	CbGbCtD
Desipramine—CYP2E1—Estrone—prostate cancer	0.0123	0.0367	CbGbCtD
Desipramine—CYP2B6—Estrone—prostate cancer	0.0121	0.0362	CbGbCtD
Desipramine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0118	0.0353	CbGbCtD
Desipramine—SLC22A1—Estradiol—prostate cancer	0.0116	0.0348	CbGbCtD
Desipramine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0108	0.0323	CbGbCtD
Desipramine—CYP2C19—Flutamide—prostate cancer	0.0106	0.0318	CbGbCtD
Desipramine—CYP1A2—Flutamide—prostate cancer	0.00983	0.0294	CbGbCtD
Desipramine—CYP2D6—Bicalutamide—prostate cancer	0.00977	0.0292	CbGbCtD
Desipramine—ABCB1—Estramustine—prostate cancer	0.00964	0.0288	CbGbCtD
Desipramine—CYP2D6—Abiraterone—prostate cancer	0.0081	0.0242	CbGbCtD
Desipramine—CYP2E1—Mitoxantrone—prostate cancer	0.00731	0.0218	CbGbCtD
Desipramine—CYP1A2—Estrone—prostate cancer	0.0071	0.0212	CbGbCtD
Desipramine—ABCB1—Cabazitaxel—prostate cancer	0.00636	0.019	CbGbCtD
Desipramine—CYP3A4—Bicalutamide—prostate cancer	0.00621	0.0186	CbGbCtD
Desipramine—ABCB1—Estrone—prostate cancer	0.00621	0.0186	CbGbCtD
Desipramine—CYP3A4—Estramustine—prostate cancer	0.00578	0.0173	CbGbCtD
Desipramine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00554	0.0165	CbGbCtD
Desipramine—CYP3A4—Flutamide—prostate cancer	0.00515	0.0154	CbGbCtD
Desipramine—CYP3A4—Abiraterone—prostate cancer	0.00515	0.0154	CbGbCtD
Desipramine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00465	0.0139	CbGbCtD
Desipramine—CYP2E1—Etoposide—prostate cancer	0.00461	0.0138	CbGbCtD
Desipramine—CYP2C19—Estradiol—prostate cancer	0.00442	0.0132	CbGbCtD
Desipramine—CHRM3—ureter—prostate cancer	0.00431	0.115	CbGeAlD
Desipramine—CYP1A2—Estradiol—prostate cancer	0.00408	0.0122	CbGbCtD
Desipramine—ABCB1—Conjugated Estrogens—prostate cancer	0.00406	0.0121	CbGbCtD
Desipramine—CYP3A4—Cabazitaxel—prostate cancer	0.00381	0.0114	CbGbCtD
Desipramine—CYP2C19—Prednisone—prostate cancer	0.0038	0.0114	CbGbCtD
Desipramine—SMPD1—urine—prostate cancer	0.00376	0.101	CbGeAlD
Desipramine—CYP3A4—Estrone—prostate cancer	0.00372	0.0111	CbGbCtD
Desipramine—ABCB1—Mitoxantrone—prostate cancer	0.00369	0.011	CbGbCtD
Desipramine—ABCB1—Estradiol—prostate cancer	0.00357	0.0107	CbGbCtD
Desipramine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00332	0.00991	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—prostate cancer	0.0031	0.00926	CbGbCtD
Desipramine—ABCB1—Prednisone—prostate cancer	0.00307	0.00917	CbGbCtD
Desipramine—CYP1A2—Etoposide—prostate cancer	0.00266	0.00796	CbGbCtD
Desipramine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00243	0.00727	CbGbCtD
Desipramine—ABCB1—Etoposide—prostate cancer	0.00233	0.00696	CbGbCtD
Desipramine—CYP3A4—Mitoxantrone—prostate cancer	0.00221	0.00661	CbGbCtD
Desipramine—CYP3A4—Estradiol—prostate cancer	0.00214	0.00639	CbGbCtD
Desipramine—ABCB1—Docetaxel—prostate cancer	0.00213	0.00637	CbGbCtD
Desipramine—CYP3A4—Prednisone—prostate cancer	0.00184	0.00549	CbGbCtD
Desipramine—ABCB1—Doxorubicin—prostate cancer	0.00159	0.00475	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—prostate cancer	0.0015	0.00447	CbGbCtD
Desipramine—CYP3A4—Etoposide—prostate cancer	0.0014	0.00417	CbGbCtD
Desipramine—SMPD1—prostate gland—prostate cancer	0.00135	0.0362	CbGeAlD
Desipramine—CYP2C19—urine—prostate cancer	0.0013	0.0349	CbGeAlD
Desipramine—CYP3A4—Docetaxel—prostate cancer	0.00128	0.00382	CbGbCtD
Desipramine—CYP1A2—urine—prostate cancer	0.00106	0.0285	CbGeAlD
Desipramine—CYP2E1—urine—prostate cancer	0.000956	0.0256	CbGeAlD
Desipramine—CYP3A4—Doxorubicin—prostate cancer	0.000952	0.00284	CbGbCtD
Desipramine—SMPD1—renal system—prostate cancer	0.000921	0.0247	CbGeAlD
Desipramine—HTR2A—urine—prostate cancer	0.000831	0.0223	CbGeAlD
Desipramine—CYP3A4—urine—prostate cancer	0.00077	0.0206	CbGeAlD
Desipramine—CYP2D6—urine—prostate cancer	0.000757	0.0203	CbGeAlD
Desipramine—CYP2A6—prostate gland—prostate cancer	0.000727	0.0195	CbGeAlD
Desipramine—ORM1—prostate gland—prostate cancer	0.000662	0.0177	CbGeAlD
Desipramine—CHRM5—epithelium—prostate cancer	0.000661	0.0177	CbGeAlD
Desipramine—SLC22A4—prostate gland—prostate cancer	0.000637	0.017	CbGeAlD
Desipramine—CHRM2—prostate gland—prostate cancer	0.000617	0.0165	CbGeAlD
Desipramine—CYP2A6—seminal vesicle—prostate cancer	0.000615	0.0165	CbGeAlD
Desipramine—SMPD1—testis—prostate cancer	0.000595	0.0159	CbGeAlD
Desipramine—SLC22A2—renal system—prostate cancer	0.000585	0.0157	CbGeAlD
Desipramine—ADRB1—prostate gland—prostate cancer	0.000584	0.0156	CbGeAlD
Desipramine—SLC22A3—prostate gland—prostate cancer	0.000579	0.0155	CbGeAlD
Desipramine—CHRM1—prostate gland—prostate cancer	0.000562	0.015	CbGeAlD
Desipramine—SLC22A4—seminal vesicle—prostate cancer	0.000538	0.0144	CbGeAlD
Desipramine—CHRM4—testis—prostate cancer	0.000507	0.0136	CbGeAlD
Desipramine—CHRM3—prostate gland—prostate cancer	0.000503	0.0135	CbGeAlD
Desipramine—SLC22A3—seminal vesicle—prostate cancer	0.00049	0.0131	CbGeAlD
Desipramine—SLC22A4—renal system—prostate cancer	0.000434	0.0116	CbGeAlD
Desipramine—SMPD1—lymph node—prostate cancer	0.000432	0.0116	CbGeAlD
Desipramine—SLC22A5—prostate gland—prostate cancer	0.000421	0.0113	CbGeAlD
Desipramine—SLC22A1—renal system—prostate cancer	0.000413	0.0111	CbGeAlD
Desipramine—SLC22A3—renal system—prostate cancer	0.000395	0.0106	CbGeAlD
Desipramine—SLC22A3—urethra—prostate cancer	0.000388	0.0104	CbGeAlD
Desipramine—HRH1—prostate gland—prostate cancer	0.000357	0.00957	CbGeAlD
Desipramine—SLC22A5—seminal vesicle—prostate cancer	0.000356	0.00954	CbGeAlD
Desipramine—CYP2E1—prostate gland—prostate cancer	0.000343	0.00919	CbGeAlD
Desipramine—CHRM3—renal system—prostate cancer	0.000343	0.00918	CbGeAlD
Desipramine—HTR1A—renal system—prostate cancer	0.000341	0.00914	CbGeAlD
Desipramine—ORM1—bone marrow—prostate cancer	0.000341	0.00913	CbGeAlD
Desipramine—CHRM3—urethra—prostate cancer	0.000337	0.00901	CbGeAlD
Desipramine—SLC22A4—bone marrow—prostate cancer	0.000328	0.00879	CbGeAlD
Desipramine—CYP2E1—seminal vesicle—prostate cancer	0.00029	0.00778	CbGeAlD
Desipramine—SLC22A5—renal system—prostate cancer	0.000287	0.00769	CbGeAlD
Desipramine—SLC22A5—urethra—prostate cancer	0.000282	0.00755	CbGeAlD
Desipramine—SLC6A3—testis—prostate cancer	0.000271	0.00726	CbGeAlD
Desipramine—Dimetacrine—ACHE—prostate cancer	0.000271	0.105	CrCbGaD
Desipramine—HRH1—epithelium—prostate cancer	0.000263	0.00703	CbGeAlD
Desipramine—Carbamazepine—RALBP1—prostate cancer	0.000261	0.101	CrCbGaD
Desipramine—CYP1A2—renal system—prostate cancer	0.00026	0.00697	CbGeAlD
Desipramine—SLC22A3—testis—prostate cancer	0.000255	0.00683	CbGeAlD
Desipramine—CYP2B6—renal system—prostate cancer	0.000249	0.00668	CbGeAlD
Desipramine—HRH1—urethra—prostate cancer	0.000239	0.00641	CbGeAlD
Desipramine—CYP2E1—renal system—prostate cancer	0.000234	0.00627	CbGeAlD
Desipramine—CYP2E1—urethra—prostate cancer	0.00023	0.00616	CbGeAlD
Desipramine—CHRM3—testis—prostate cancer	0.000221	0.00593	CbGeAlD
Desipramine—HTR2A—epithelium—prostate cancer	0.000219	0.00587	CbGeAlD
Desipramine—SLC6A2—testis—prostate cancer	0.000219	0.00586	CbGeAlD
Desipramine—ORM1—lymph node—prostate cancer	0.000211	0.00566	CbGeAlD
Desipramine—HTR2A—renal system—prostate cancer	0.000203	0.00545	CbGeAlD
Desipramine—SLC22A4—lymph node—prostate cancer	0.000203	0.00544	CbGeAlD
Desipramine—DRD2—testis—prostate cancer	0.000199	0.00534	CbGeAlD
Desipramine—ABCB1—prostate gland—prostate cancer	0.000196	0.00524	CbGeAlD
Desipramine—CYP3A4—renal system—prostate cancer	0.000188	0.00504	CbGeAlD
Desipramine—SLC22A5—testis—prostate cancer	0.000186	0.00497	CbGeAlD
Desipramine—CYP2D6—renal system—prostate cancer	0.000185	0.00496	CbGeAlD
Desipramine—SLC22A3—lymph node—prostate cancer	0.000185	0.00495	CbGeAlD
Desipramine—ABCB1—seminal vesicle—prostate cancer	0.000165	0.00443	CbGeAlD
Desipramine—CYP2B6—testis—prostate cancer	0.000161	0.00432	CbGeAlD
Desipramine—SLC6A2—lymph node—prostate cancer	0.000159	0.00425	CbGeAlD
Desipramine—HRH1—testis—prostate cancer	0.000157	0.00421	CbGeAlD
Desipramine—Benazepril—MTHFR—prostate cancer	0.000153	0.0595	CrCbGaD
Desipramine—CYP2E1—testis—prostate cancer	0.000151	0.00405	CbGeAlD
Desipramine—ABCB1—epithelium—prostate cancer	0.000144	0.00385	CbGeAlD
Desipramine—SLC22A5—lymph node—prostate cancer	0.000135	0.0036	CbGeAlD
Desipramine—ABCB1—renal system—prostate cancer	0.000133	0.00357	CbGeAlD
Desipramine—HTR2A—testis—prostate cancer	0.000131	0.00352	CbGeAlD
Desipramine—ABCB1—urethra—prostate cancer	0.000131	0.00351	CbGeAlD
Desipramine—Benazepril—ACE—prostate cancer	0.000125	0.0485	CrCbGaD
Desipramine—CYP2D6—testis—prostate cancer	0.00012	0.00321	CbGeAlD
Desipramine—HRH1—lymph node—prostate cancer	0.000114	0.00305	CbGeAlD
Desipramine—Oxcarbazepine—CYP3A5—prostate cancer	0.000103	0.04	CrCbGaD
Desipramine—ABCB1—bone marrow—prostate cancer	0.000101	0.0027	CbGeAlD
Desipramine—Acepromazine—SLC22A1—prostate cancer	9.66e-05	0.0375	CrCbGaD
Desipramine—ABCB1—testis—prostate cancer	8.61e-05	0.00231	CbGeAlD
Desipramine—Azatadine—CYP3A4—prostate cancer	8.38e-05	0.0325	CrCbGaD
Desipramine—Clomipramine—GSTP1—prostate cancer	7.94e-05	0.0308	CrCbGaD
Desipramine—Carbamazepine—CYP3A5—prostate cancer	7.03e-05	0.0273	CrCbGaD
Desipramine—Oxcarbazepine—CYP2C19—prostate cancer	7.02e-05	0.0272	CrCbGaD
Desipramine—Imipramine—SLC22A3—prostate cancer	6.99e-05	0.0271	CrCbGaD
Desipramine—ABCB1—lymph node—prostate cancer	6.24e-05	0.00167	CbGeAlD
Desipramine—Imipramine—CYP2C18—prostate cancer	6.14e-05	0.0238	CrCbGaD
Desipramine—Headache—Conjugated Estrogens—prostate cancer	5.82e-05	0.000526	CcSEcCtD
Desipramine—Confusional state—Etoposide—prostate cancer	5.81e-05	0.000525	CcSEcCtD
Desipramine—Nortriptyline—CYP3A5—prostate cancer	5.79e-05	0.0225	CrCbGaD
Desipramine—Hallucination—Prednisone—prostate cancer	5.78e-05	0.000523	CcSEcCtD
Desipramine—Alopecia—Capecitabine—prostate cancer	5.76e-05	0.000521	CcSEcCtD
Desipramine—Dysgeusia—Docetaxel—prostate cancer	5.74e-05	0.000519	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—prostate cancer	5.71e-05	0.000517	CcSEcCtD
Desipramine—Feeling abnormal—Mitoxantrone—prostate cancer	5.7e-05	0.000516	CcSEcCtD
Desipramine—Thrombocytopenia—Etoposide—prostate cancer	5.64e-05	0.00051	CcSEcCtD
Desipramine—Tachycardia—Etoposide—prostate cancer	5.62e-05	0.000508	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—prostate cancer	5.62e-05	0.000508	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—prostate cancer	5.61e-05	0.000507	CcSEcCtD
Desipramine—Nausea—Goserelin—prostate cancer	5.57e-05	0.000504	CcSEcCtD
Desipramine—Dysgeusia—Capecitabine—prostate cancer	5.56e-05	0.000503	CcSEcCtD
Desipramine—Nausea—Conjugated Estrogens—prostate cancer	5.51e-05	0.000499	CcSEcCtD
Desipramine—Urticaria—Mitoxantrone—prostate cancer	5.5e-05	0.000497	CcSEcCtD
Desipramine—Anorexia—Etoposide—prostate cancer	5.49e-05	0.000496	CcSEcCtD
Desipramine—Abdominal pain—Mitoxantrone—prostate cancer	5.47e-05	0.000495	CcSEcCtD
Desipramine—Body temperature increased—Mitoxantrone—prostate cancer	5.47e-05	0.000495	CcSEcCtD
Desipramine—Flushing—Prednisone—prostate cancer	5.39e-05	0.000488	CcSEcCtD
Desipramine—Hypotension—Etoposide—prostate cancer	5.38e-05	0.000487	CcSEcCtD
Desipramine—Vision blurred—Capecitabine—prostate cancer	5.35e-05	0.000484	CcSEcCtD
Desipramine—Asthenia—Estradiol—prostate cancer	5.33e-05	0.000482	CcSEcCtD
Desipramine—Tremor—Capecitabine—prostate cancer	5.32e-05	0.000481	CcSEcCtD
Desipramine—Alimemazine—CYP3A4—prostate cancer	5.3e-05	0.0206	CrCbGaD
Desipramine—Ill-defined disorder—Capecitabine—prostate cancer	5.27e-05	0.000476	CcSEcCtD
Desipramine—Pruritus—Estradiol—prostate cancer	5.26e-05	0.000475	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—prostate cancer	5.24e-05	0.000474	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—prostate cancer	5.2e-05	0.00047	CcSEcCtD
Desipramine—Arrhythmia—Prednisone—prostate cancer	5.19e-05	0.000469	CcSEcCtD
Desipramine—Palpitations—Docetaxel—prostate cancer	5.18e-05	0.000469	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—prostate cancer	5.17e-05	0.000468	CcSEcCtD
Desipramine—Weight increased—Epirubicin—prostate cancer	5.17e-05	0.000467	CcSEcCtD
Desipramine—Alopecia—Prednisone—prostate cancer	5.13e-05	0.000464	CcSEcCtD
Desipramine—Malaise—Capecitabine—prostate cancer	5.12e-05	0.000463	CcSEcCtD
Desipramine—Somnolence—Etoposide—prostate cancer	5.12e-05	0.000463	CcSEcCtD
Desipramine—Diarrhoea—Estradiol—prostate cancer	5.08e-05	0.00046	CcSEcCtD
Desipramine—Convulsion—Docetaxel—prostate cancer	5.08e-05	0.00046	CcSEcCtD
Desipramine—Hypertension—Docetaxel—prostate cancer	5.06e-05	0.000458	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—prostate cancer	5.06e-05	0.000458	CcSEcCtD
Desipramine—Chlorpromazine—SLC22A1—prostate cancer	5.04e-05	0.0195	CrCbGaD
Desipramine—Palpitations—Capecitabine—prostate cancer	5.02e-05	0.000454	CcSEcCtD
Desipramine—Imipramine—SLC22A1—prostate cancer	5.01e-05	0.0194	CrCbGaD
Desipramine—Decreased appetite—Etoposide—prostate cancer	5.01e-05	0.000453	CcSEcCtD
Desipramine—Asthenia—Mitoxantrone—prostate cancer	4.97e-05	0.000449	CcSEcCtD
Desipramine—Fatigue—Etoposide—prostate cancer	4.96e-05	0.000449	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—prostate cancer	4.96e-05	0.000449	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—prostate cancer	4.93e-05	0.000446	CcSEcCtD
Desipramine—Jaundice—Epirubicin—prostate cancer	4.93e-05	0.000446	CcSEcCtD
Desipramine—Constipation—Etoposide—prostate cancer	4.92e-05	0.000445	CcSEcCtD
Desipramine—Dizziness—Estradiol—prostate cancer	4.91e-05	0.000444	CcSEcCtD
Desipramine—Hypertension—Capecitabine—prostate cancer	4.9e-05	0.000443	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—prostate cancer	4.88e-05	0.000442	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—prostate cancer	4.85e-05	0.000439	CcSEcCtD
Desipramine—Epinastine—CYP3A4—prostate cancer	4.85e-05	0.0188	CrCbGaD
Desipramine—Confusional state—Docetaxel—prostate cancer	4.83e-05	0.000436	CcSEcCtD
Desipramine—Anxiety—Capecitabine—prostate cancer	4.82e-05	0.000436	CcSEcCtD
Desipramine—Oedema—Docetaxel—prostate cancer	4.79e-05	0.000433	CcSEcCtD
Desipramine—Carbamazepine—CYP2C19—prostate cancer	4.79e-05	0.0186	CrCbGaD
Desipramine—Weight increased—Doxorubicin—prostate cancer	4.78e-05	0.000432	CcSEcCtD
Desipramine—Discomfort—Capecitabine—prostate cancer	4.78e-05	0.000432	CcSEcCtD
Desipramine—Vision blurred—Prednisone—prostate cancer	4.77e-05	0.000431	CcSEcCtD
Desipramine—Feeling abnormal—Etoposide—prostate cancer	4.75e-05	0.000429	CcSEcCtD
Desipramine—Diarrhoea—Mitoxantrone—prostate cancer	4.74e-05	0.000428	CcSEcCtD
Desipramine—Dry mouth—Capecitabine—prostate cancer	4.73e-05	0.000428	CcSEcCtD
Desipramine—Vomiting—Estradiol—prostate cancer	4.72e-05	0.000427	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—prostate cancer	4.72e-05	0.000427	CcSEcCtD
Desipramine—Ill-defined disorder—Prednisone—prostate cancer	4.69e-05	0.000424	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—prostate cancer	4.69e-05	0.000424	CcSEcCtD
Desipramine—Rash—Estradiol—prostate cancer	4.68e-05	0.000424	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—prostate cancer	4.68e-05	0.000424	CcSEcCtD
Desipramine—Dermatitis—Estradiol—prostate cancer	4.68e-05	0.000423	CcSEcCtD
Desipramine—Confusional state—Capecitabine—prostate cancer	4.67e-05	0.000423	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—prostate cancer	4.67e-05	0.000422	CcSEcCtD
Desipramine—Headache—Estradiol—prostate cancer	4.65e-05	0.000421	CcSEcCtD
Desipramine—Agitation—Prednisone—prostate cancer	4.65e-05	0.00042	CcSEcCtD
Desipramine—Oedema—Capecitabine—prostate cancer	4.63e-05	0.000419	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—prostate cancer	4.59e-05	0.000415	CcSEcCtD
Desipramine—Urticaria—Etoposide—prostate cancer	4.57e-05	0.000414	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—prostate cancer	4.56e-05	0.000413	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—prostate cancer	4.56e-05	0.000413	CcSEcCtD
Desipramine—Anorexia—Docetaxel—prostate cancer	4.56e-05	0.000413	CcSEcCtD
Desipramine—Mequitazine—CYP3A4—prostate cancer	4.56e-05	0.0177	CrCbGaD
Desipramine—Malaise—Prednisone—prostate cancer	4.56e-05	0.000412	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—prostate cancer	4.55e-05	0.000412	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—prostate cancer	4.55e-05	0.000412	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—prostate cancer	4.54e-05	0.000411	CcSEcCtD
Desipramine—Thrombocytopenia—Capecitabine—prostate cancer	4.54e-05	0.00041	CcSEcCtD
Desipramine—Tachycardia—Capecitabine—prostate cancer	4.52e-05	0.000409	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—prostate cancer	4.52e-05	0.000409	CcSEcCtD
Desipramine—Atomoxetine—CYP2C19—prostate cancer	4.51e-05	0.0175	CrCbGaD
Desipramine—Hypotension—Docetaxel—prostate cancer	4.47e-05	0.000404	CcSEcCtD
Desipramine—Oxcarbazepine—CYP3A4—prostate cancer	4.46e-05	0.0173	CrCbGaD
Desipramine—Anorexia—Capecitabine—prostate cancer	4.42e-05	0.000399	CcSEcCtD
Desipramine—Nausea—Estradiol—prostate cancer	4.41e-05	0.000399	CcSEcCtD
Desipramine—Vomiting—Mitoxantrone—prostate cancer	4.4e-05	0.000398	CcSEcCtD
Desipramine—Convulsion—Prednisone—prostate cancer	4.38e-05	0.000396	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—prostate cancer	4.37e-05	0.000395	CcSEcCtD
Desipramine—Hypertension—Prednisone—prostate cancer	4.37e-05	0.000395	CcSEcCtD
Desipramine—Rash—Mitoxantrone—prostate cancer	4.37e-05	0.000395	CcSEcCtD
Desipramine—Dermatitis—Mitoxantrone—prostate cancer	4.36e-05	0.000394	CcSEcCtD
Desipramine—Headache—Mitoxantrone—prostate cancer	4.34e-05	0.000392	CcSEcCtD
Desipramine—Hypotension—Capecitabine—prostate cancer	4.33e-05	0.000392	CcSEcCtD
Desipramine—Insomnia—Docetaxel—prostate cancer	4.33e-05	0.000391	CcSEcCtD
Desipramine—Paraesthesia—Docetaxel—prostate cancer	4.3e-05	0.000389	CcSEcCtD
Desipramine—Anxiety—Prednisone—prostate cancer	4.29e-05	0.000388	CcSEcCtD
Desipramine—Somnolence—Docetaxel—prostate cancer	4.25e-05	0.000385	CcSEcCtD
Desipramine—Discomfort—Prednisone—prostate cancer	4.25e-05	0.000385	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—prostate cancer	4.24e-05	0.000383	CcSEcCtD
Desipramine—Flushing—Epirubicin—prostate cancer	4.22e-05	0.000381	CcSEcCtD
Desipramine—Dyspepsia—Docetaxel—prostate cancer	4.21e-05	0.000381	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—prostate cancer	4.2e-05	0.00038	CcSEcCtD
Desipramine—Insomnia—Capecitabine—prostate cancer	4.19e-05	0.000379	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—prostate cancer	4.18e-05	0.000378	CcSEcCtD
Desipramine—Paraesthesia—Capecitabine—prostate cancer	4.16e-05	0.000376	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—prostate cancer	4.16e-05	0.000376	CcSEcCtD
Desipramine—Asthenia—Etoposide—prostate cancer	4.13e-05	0.000374	CcSEcCtD
Desipramine—Oedema—Prednisone—prostate cancer	4.13e-05	0.000373	CcSEcCtD
Desipramine—Fatigue—Docetaxel—prostate cancer	4.13e-05	0.000373	CcSEcCtD
Desipramine—Nausea—Mitoxantrone—prostate cancer	4.11e-05	0.000372	CcSEcCtD
Desipramine—Constipation—Docetaxel—prostate cancer	4.09e-05	0.00037	CcSEcCtD
Desipramine—Dyspepsia—Capecitabine—prostate cancer	4.08e-05	0.000369	CcSEcCtD
Desipramine—Pruritus—Etoposide—prostate cancer	4.07e-05	0.000368	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—prostate cancer	4.06e-05	0.000367	CcSEcCtD
Desipramine—Clomipramine—CYP2C19—prostate cancer	4.03e-05	0.0156	CrCbGaD
Desipramine—Tachycardia—Prednisone—prostate cancer	4.03e-05	0.000364	CcSEcCtD
Desipramine—Decreased appetite—Capecitabine—prostate cancer	4.03e-05	0.000364	CcSEcCtD
Desipramine—Amitriptyline—CYP3A5—prostate cancer	4.02e-05	0.0156	CrCbGaD
Desipramine—Alopecia—Epirubicin—prostate cancer	4.01e-05	0.000363	CcSEcCtD
Desipramine—Fatigue—Capecitabine—prostate cancer	3.99e-05	0.000361	CcSEcCtD
Desipramine—Nortriptyline—CYP2E1—prostate cancer	3.98e-05	0.0154	CrCbGaD
Desipramine—Constipation—Capecitabine—prostate cancer	3.96e-05	0.000358	CcSEcCtD
Desipramine—Feeling abnormal—Docetaxel—prostate cancer	3.94e-05	0.000357	CcSEcCtD
Desipramine—Nortriptyline—CYP2C19—prostate cancer	3.94e-05	0.0153	CrCbGaD
Desipramine—Diarrhoea—Etoposide—prostate cancer	3.94e-05	0.000356	CcSEcCtD
Desipramine—Anorexia—Prednisone—prostate cancer	3.93e-05	0.000356	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—prostate cancer	3.92e-05	0.000355	CcSEcCtD
Desipramine—Flushing—Doxorubicin—prostate cancer	3.9e-05	0.000353	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—prostate cancer	3.87e-05	0.00035	CcSEcCtD
Desipramine—Feeling abnormal—Capecitabine—prostate cancer	3.82e-05	0.000345	CcSEcCtD
Desipramine—Dizziness—Etoposide—prostate cancer	3.81e-05	0.000344	CcSEcCtD
Desipramine—Body temperature increased—Docetaxel—prostate cancer	3.78e-05	0.000342	CcSEcCtD
Desipramine—Abdominal pain—Docetaxel—prostate cancer	3.78e-05	0.000342	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—prostate cancer	3.76e-05	0.00034	CcSEcCtD
Desipramine—Insomnia—Prednisone—prostate cancer	3.73e-05	0.000338	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—prostate cancer	3.73e-05	0.000337	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—prostate cancer	3.71e-05	0.000336	CcSEcCtD
Desipramine—Trimipramine—CYP2C19—prostate cancer	3.71e-05	0.0144	CrCbGaD
Desipramine—Paraesthesia—Prednisone—prostate cancer	3.71e-05	0.000335	CcSEcCtD
Desipramine—Urticaria—Capecitabine—prostate cancer	3.68e-05	0.000333	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—prostate cancer	3.67e-05	0.000332	CcSEcCtD
Desipramine—Abdominal pain—Capecitabine—prostate cancer	3.66e-05	0.000331	CcSEcCtD
Desipramine—Body temperature increased—Capecitabine—prostate cancer	3.66e-05	0.000331	CcSEcCtD
Desipramine—Vomiting—Etoposide—prostate cancer	3.66e-05	0.000331	CcSEcCtD
Desipramine—Agitation—Epirubicin—prostate cancer	3.63e-05	0.000329	CcSEcCtD
Desipramine—Dyspepsia—Prednisone—prostate cancer	3.63e-05	0.000329	CcSEcCtD
Desipramine—Rash—Etoposide—prostate cancer	3.63e-05	0.000328	CcSEcCtD
Desipramine—Dermatitis—Etoposide—prostate cancer	3.63e-05	0.000328	CcSEcCtD
Desipramine—Headache—Etoposide—prostate cancer	3.61e-05	0.000326	CcSEcCtD
Desipramine—Decreased appetite—Prednisone—prostate cancer	3.59e-05	0.000324	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—prostate cancer	3.58e-05	0.000324	CcSEcCtD
Desipramine—Malaise—Epirubicin—prostate cancer	3.57e-05	0.000323	CcSEcCtD
Desipramine—Fatigue—Prednisone—prostate cancer	3.56e-05	0.000322	CcSEcCtD
Desipramine—Doxepin—CYP2C19—prostate cancer	3.54e-05	0.0137	CrCbGaD
Desipramine—Constipation—Prednisone—prostate cancer	3.53e-05	0.000319	CcSEcCtD
Desipramine—Palpitations—Epirubicin—prostate cancer	3.5e-05	0.000316	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—prostate cancer	3.45e-05	0.000312	CcSEcCtD
Desipramine—Asthenia—Docetaxel—prostate cancer	3.43e-05	0.000311	CcSEcCtD
Desipramine—Convulsion—Epirubicin—prostate cancer	3.43e-05	0.00031	CcSEcCtD
Desipramine—Nausea—Etoposide—prostate cancer	3.42e-05	0.000309	CcSEcCtD
Desipramine—Hypertension—Epirubicin—prostate cancer	3.41e-05	0.000309	CcSEcCtD
Desipramine—Feeling abnormal—Prednisone—prostate cancer	3.4e-05	0.000308	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—prostate cancer	3.4e-05	0.000307	CcSEcCtD
Desipramine—Pruritus—Docetaxel—prostate cancer	3.39e-05	0.000306	CcSEcCtD
Desipramine—Agitation—Doxorubicin—prostate cancer	3.36e-05	0.000304	CcSEcCtD
Desipramine—Anxiety—Epirubicin—prostate cancer	3.36e-05	0.000303	CcSEcCtD
Desipramine—Discomfort—Epirubicin—prostate cancer	3.33e-05	0.000301	CcSEcCtD
Desipramine—Asthenia—Capecitabine—prostate cancer	3.32e-05	0.000301	CcSEcCtD
Desipramine—Malaise—Doxorubicin—prostate cancer	3.3e-05	0.000298	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—prostate cancer	3.29e-05	0.000298	CcSEcCtD
Desipramine—Urticaria—Prednisone—prostate cancer	3.28e-05	0.000297	CcSEcCtD
Desipramine—Pruritus—Capecitabine—prostate cancer	3.28e-05	0.000296	CcSEcCtD
Desipramine—Diarrhoea—Docetaxel—prostate cancer	3.27e-05	0.000296	CcSEcCtD
Desipramine—Body temperature increased—Prednisone—prostate cancer	3.26e-05	0.000295	CcSEcCtD
Desipramine—Abdominal pain—Prednisone—prostate cancer	3.26e-05	0.000295	CcSEcCtD
Desipramine—Confusional state—Epirubicin—prostate cancer	3.25e-05	0.000294	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—prostate cancer	3.23e-05	0.000292	CcSEcCtD
Desipramine—Oedema—Epirubicin—prostate cancer	3.23e-05	0.000292	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—prostate cancer	3.17e-05	0.000287	CcSEcCtD
Desipramine—Diarrhoea—Capecitabine—prostate cancer	3.17e-05	0.000287	CcSEcCtD
Desipramine—Dizziness—Docetaxel—prostate cancer	3.16e-05	0.000286	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—prostate cancer	3.16e-05	0.000286	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—prostate cancer	3.16e-05	0.000286	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—prostate cancer	3.15e-05	0.000285	CcSEcCtD
Desipramine—Promazine—CYP2C19—prostate cancer	3.14e-05	0.0122	CrCbGaD
Desipramine—Anxiety—Doxorubicin—prostate cancer	3.1e-05	0.000281	CcSEcCtD
Desipramine—Prochlorperazine—CYP3A4—prostate cancer	3.1e-05	0.012	CrCbGaD
Desipramine—Discomfort—Doxorubicin—prostate cancer	3.08e-05	0.000278	CcSEcCtD
Desipramine—Anorexia—Epirubicin—prostate cancer	3.08e-05	0.000278	CcSEcCtD
Desipramine—Dizziness—Capecitabine—prostate cancer	3.06e-05	0.000277	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—prostate cancer	3.05e-05	0.000276	CcSEcCtD
Desipramine—Carbamazepine—CYP3A4—prostate cancer	3.04e-05	0.0118	CrCbGaD
Desipramine—Vomiting—Docetaxel—prostate cancer	3.04e-05	0.000275	CcSEcCtD
Desipramine—Rash—Docetaxel—prostate cancer	3.02e-05	0.000273	CcSEcCtD
Desipramine—Hypotension—Epirubicin—prostate cancer	3.02e-05	0.000273	CcSEcCtD
Desipramine—Dermatitis—Docetaxel—prostate cancer	3.01e-05	0.000273	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—prostate cancer	3.01e-05	0.000272	CcSEcCtD
Desipramine—Headache—Docetaxel—prostate cancer	3e-05	0.000271	CcSEcCtD
Desipramine—Oedema—Doxorubicin—prostate cancer	2.99e-05	0.00027	CcSEcCtD
Desipramine—Asthenia—Prednisone—prostate cancer	2.96e-05	0.000268	CcSEcCtD
Desipramine—Vomiting—Capecitabine—prostate cancer	2.95e-05	0.000266	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—prostate cancer	2.92e-05	0.000264	CcSEcCtD
Desipramine—Rash—Capecitabine—prostate cancer	2.92e-05	0.000264	CcSEcCtD
Desipramine—Pruritus—Prednisone—prostate cancer	2.92e-05	0.000264	CcSEcCtD
Desipramine—Insomnia—Epirubicin—prostate cancer	2.92e-05	0.000264	CcSEcCtD
Desipramine—Dermatitis—Capecitabine—prostate cancer	2.92e-05	0.000264	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—prostate cancer	2.91e-05	0.000264	CcSEcCtD
Desipramine—Headache—Capecitabine—prostate cancer	2.9e-05	0.000263	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—prostate cancer	2.9e-05	0.000262	CcSEcCtD
Desipramine—Somnolence—Epirubicin—prostate cancer	2.87e-05	0.00026	CcSEcCtD
Desipramine—Atomoxetine—CYP3A4—prostate cancer	2.87e-05	0.0111	CrCbGaD
Desipramine—Anorexia—Doxorubicin—prostate cancer	2.85e-05	0.000257	CcSEcCtD
Desipramine—Nausea—Docetaxel—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Desipramine—Diarrhoea—Prednisone—prostate cancer	2.82e-05	0.000255	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—prostate cancer	2.81e-05	0.000254	CcSEcCtD
Desipramine—Mianserin—CYP3A4—prostate cancer	2.8e-05	0.0109	CrCbGaD
Desipramine—Chlorpromazine—CYP2E1—prostate cancer	2.79e-05	0.0108	CrCbGaD
Desipramine—Hypotension—Doxorubicin—prostate cancer	2.79e-05	0.000252	CcSEcCtD
Desipramine—Fatigue—Epirubicin—prostate cancer	2.78e-05	0.000252	CcSEcCtD
Desipramine—Imipramine—CYP2E1—prostate cancer	2.78e-05	0.0108	CrCbGaD
Desipramine—Amitriptyline—CYP2E1—prostate cancer	2.76e-05	0.0107	CrCbGaD
Desipramine—Constipation—Epirubicin—prostate cancer	2.76e-05	0.00025	CcSEcCtD
Desipramine—Nausea—Capecitabine—prostate cancer	2.75e-05	0.000249	CcSEcCtD
Desipramine—Imipramine—CYP2C19—prostate cancer	2.75e-05	0.0107	CrCbGaD
Desipramine—Amitriptyline—CYP2C19—prostate cancer	2.73e-05	0.0106	CrCbGaD
Desipramine—Dizziness—Prednisone—prostate cancer	2.73e-05	0.000247	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—prostate cancer	2.7e-05	0.000244	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—prostate cancer	2.68e-05	0.000243	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—prostate cancer	2.66e-05	0.000241	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—prostate cancer	2.66e-05	0.00024	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—prostate cancer	2.63e-05	0.000238	CcSEcCtD
Desipramine—Vomiting—Prednisone—prostate cancer	2.62e-05	0.000237	CcSEcCtD
Desipramine—Rash—Prednisone—prostate cancer	2.6e-05	0.000235	CcSEcCtD
Desipramine—Dermatitis—Prednisone—prostate cancer	2.6e-05	0.000235	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—prostate cancer	2.6e-05	0.000235	CcSEcCtD
Desipramine—Headache—Prednisone—prostate cancer	2.59e-05	0.000234	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—prostate cancer	2.58e-05	0.000233	CcSEcCtD
Desipramine—Urticaria—Epirubicin—prostate cancer	2.56e-05	0.000232	CcSEcCtD
Desipramine—Clomipramine—CYP3A4—prostate cancer	2.56e-05	0.00995	CrCbGaD
Desipramine—Constipation—Doxorubicin—prostate cancer	2.55e-05	0.000231	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—prostate cancer	2.55e-05	0.000231	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—prostate cancer	2.55e-05	0.000231	CcSEcCtD
Desipramine—Nortriptyline—CYP3A4—prostate cancer	2.51e-05	0.00973	CrCbGaD
Desipramine—Feeling abnormal—Doxorubicin—prostate cancer	2.46e-05	0.000223	CcSEcCtD
Desipramine—Nausea—Prednisone—prostate cancer	2.45e-05	0.000222	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—prostate cancer	2.37e-05	0.000215	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—prostate cancer	2.36e-05	0.000214	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—prostate cancer	2.36e-05	0.000214	CcSEcCtD
Desipramine—Trimipramine—CYP3A4—prostate cancer	2.36e-05	0.00916	CrCbGaD
Desipramine—Asthenia—Epirubicin—prostate cancer	2.32e-05	0.000209	CcSEcCtD
Desipramine—Pruritus—Epirubicin—prostate cancer	2.28e-05	0.000207	CcSEcCtD
Desipramine—Doxepin—CYP3A4—prostate cancer	2.25e-05	0.00873	CrCbGaD
Desipramine—Diarrhoea—Epirubicin—prostate cancer	2.21e-05	0.0002	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—prostate cancer	2.14e-05	0.000194	CcSEcCtD
Desipramine—Dizziness—Epirubicin—prostate cancer	2.13e-05	0.000193	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—prostate cancer	2.11e-05	0.000191	CcSEcCtD
Desipramine—Vomiting—Epirubicin—prostate cancer	2.05e-05	0.000186	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—prostate cancer	2.04e-05	0.000185	CcSEcCtD
Desipramine—Rash—Epirubicin—prostate cancer	2.04e-05	0.000184	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—prostate cancer	2.03e-05	0.000184	CcSEcCtD
Desipramine—Headache—Epirubicin—prostate cancer	2.02e-05	0.000183	CcSEcCtD
Desipramine—Promazine—CYP3A4—prostate cancer	2e-05	0.00776	CrCbGaD
Desipramine—Dizziness—Doxorubicin—prostate cancer	1.98e-05	0.000179	CcSEcCtD
Desipramine—Nausea—Epirubicin—prostate cancer	1.92e-05	0.000173	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Desipramine—Rash—Doxorubicin—prostate cancer	1.88e-05	0.00017	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—prostate cancer	1.88e-05	0.00017	CcSEcCtD
Desipramine—Headache—Doxorubicin—prostate cancer	1.87e-05	0.000169	CcSEcCtD
Desipramine—Nausea—Doxorubicin—prostate cancer	1.77e-05	0.00016	CcSEcCtD
Desipramine—Chlorpromazine—CYP3A4—prostate cancer	1.76e-05	0.00683	CrCbGaD
Desipramine—Imipramine—CYP3A4—prostate cancer	1.75e-05	0.00679	CrCbGaD
Desipramine—Amitriptyline—CYP3A4—prostate cancer	1.74e-05	0.00675	CrCbGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	6.89e-07	6.94e-06	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	6.89e-07	6.94e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—prostate cancer	6.88e-07	6.93e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—prostate cancer	6.87e-07	6.92e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—prostate cancer	6.87e-07	6.92e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—prostate cancer	6.86e-07	6.91e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARA—prostate cancer	6.85e-07	6.9e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—prostate cancer	6.84e-07	6.89e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—prostate cancer	6.84e-07	6.89e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—prostate cancer	6.84e-07	6.89e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—prostate cancer	6.83e-07	6.88e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—prostate cancer	6.82e-07	6.87e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—prostate cancer	6.82e-07	6.87e-06	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	6.82e-07	6.87e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—prostate cancer	6.81e-07	6.86e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CREBBP—prostate cancer	6.81e-07	6.86e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—prostate cancer	6.81e-07	6.86e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—prostate cancer	6.8e-07	6.85e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—prostate cancer	6.78e-07	6.83e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	6.76e-07	6.81e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—prostate cancer	6.76e-07	6.81e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—prostate cancer	6.75e-07	6.8e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	6.74e-07	6.79e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—prostate cancer	6.73e-07	6.78e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	6.72e-07	6.77e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—prostate cancer	6.71e-07	6.76e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—prostate cancer	6.7e-07	6.75e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—prostate cancer	6.69e-07	6.74e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—prostate cancer	6.68e-07	6.73e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COMT—prostate cancer	6.66e-07	6.71e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—prostate cancer	6.66e-07	6.71e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—prostate cancer	6.66e-07	6.71e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—prostate cancer	6.64e-07	6.69e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	6.63e-07	6.68e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—prostate cancer	6.63e-07	6.68e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	6.62e-07	6.67e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—prostate cancer	6.62e-07	6.66e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—prostate cancer	6.61e-07	6.66e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	6.6e-07	6.65e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—prostate cancer	6.59e-07	6.64e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	6.58e-07	6.63e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—prostate cancer	6.58e-07	6.62e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	6.58e-07	6.62e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—prostate cancer	6.57e-07	6.62e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—INS—prostate cancer	6.55e-07	6.6e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ITPR1—prostate cancer	6.53e-07	6.57e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	6.51e-07	6.56e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—prostate cancer	6.51e-07	6.56e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—prostate cancer	6.5e-07	6.55e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—prostate cancer	6.5e-07	6.55e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—prostate cancer	6.49e-07	6.54e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	6.49e-07	6.53e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	6.48e-07	6.53e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—prostate cancer	6.47e-07	6.52e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	6.47e-07	6.51e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—prostate cancer	6.46e-07	6.51e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—prostate cancer	6.46e-07	6.51e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—prostate cancer	6.46e-07	6.51e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—prostate cancer	6.45e-07	6.5e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—prostate cancer	6.45e-07	6.49e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	6.44e-07	6.49e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	6.44e-07	6.49e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAV1—prostate cancer	6.44e-07	6.49e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—prostate cancer	6.43e-07	6.48e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	6.42e-07	6.47e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CREBBP—prostate cancer	6.42e-07	6.47e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—prostate cancer	6.41e-07	6.46e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—prostate cancer	6.41e-07	6.46e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—prostate cancer	6.38e-07	6.43e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	6.36e-07	6.41e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—prostate cancer	6.36e-07	6.41e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—prostate cancer	6.36e-07	6.41e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—prostate cancer	6.35e-07	6.39e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	6.34e-07	6.39e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	6.31e-07	6.35e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—prostate cancer	6.29e-07	6.34e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—prostate cancer	6.29e-07	6.34e-06	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—prostate cancer	6.28e-07	6.33e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	6.27e-07	6.32e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—prostate cancer	6.27e-07	6.31e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	6.25e-07	6.3e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NOS3—prostate cancer	6.25e-07	6.29e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—prostate cancer	6.23e-07	6.28e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—prostate cancer	6.22e-07	6.27e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—prostate cancer	6.22e-07	6.26e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	6.2e-07	6.25e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	6.19e-07	6.24e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—prostate cancer	6.19e-07	6.23e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	6.17e-07	6.22e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—prostate cancer	6.17e-07	6.21e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—prostate cancer	6.16e-07	6.21e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—prostate cancer	6.16e-07	6.21e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—prostate cancer	6.15e-07	6.2e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.15e-07	6.2e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—prostate cancer	6.13e-07	6.18e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—prostate cancer	6.11e-07	6.16e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NOS3—prostate cancer	6.1e-07	6.14e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—prostate cancer	6.09e-07	6.14e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—prostate cancer	6.09e-07	6.14e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.08e-07	6.13e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—prostate cancer	6.08e-07	6.13e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—prostate cancer	6.05e-07	6.1e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—prostate cancer	6.05e-07	6.1e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—prostate cancer	6.01e-07	6.05e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—prostate cancer	5.99e-07	6.04e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—LPL—prostate cancer	5.98e-07	6.03e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—prostate cancer	5.98e-07	6.03e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—prostate cancer	5.96e-07	6.01e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—prostate cancer	5.96e-07	6e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—prostate cancer	5.94e-07	5.99e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—prostate cancer	5.93e-07	5.98e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—prostate cancer	5.89e-07	5.93e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—prostate cancer	5.88e-07	5.92e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—prostate cancer	5.88e-07	5.92e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—prostate cancer	5.86e-07	5.91e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—prostate cancer	5.85e-07	5.9e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	5.84e-07	5.88e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—prostate cancer	5.83e-07	5.87e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	5.81e-07	5.85e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	5.79e-07	5.83e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—prostate cancer	5.78e-07	5.82e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.78e-07	5.82e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—prostate cancer	5.77e-07	5.81e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—prostate cancer	5.77e-07	5.81e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—prostate cancer	5.77e-07	5.81e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—prostate cancer	5.75e-07	5.79e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NOS3—prostate cancer	5.75e-07	5.79e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—prostate cancer	5.75e-07	5.79e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	5.73e-07	5.78e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—prostate cancer	5.73e-07	5.77e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ERCC2—prostate cancer	5.73e-07	5.77e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—prostate cancer	5.72e-07	5.76e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—prostate cancer	5.71e-07	5.76e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—prostate cancer	5.7e-07	5.75e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—prostate cancer	5.68e-07	5.72e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—prostate cancer	5.63e-07	5.67e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—prostate cancer	5.58e-07	5.62e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—INS—prostate cancer	5.55e-07	5.59e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	5.52e-07	5.56e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—prostate cancer	5.5e-07	5.54e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—prostate cancer	5.46e-07	5.5e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—prostate cancer	5.45e-07	5.49e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CREBBP—prostate cancer	5.44e-07	5.48e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—prostate cancer	5.41e-07	5.45e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	5.4e-07	5.44e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—prostate cancer	5.39e-07	5.43e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—prostate cancer	5.37e-07	5.41e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—prostate cancer	5.36e-07	5.4e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	5.36e-07	5.4e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—prostate cancer	5.35e-07	5.39e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—prostate cancer	5.34e-07	5.38e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—prostate cancer	5.34e-07	5.38e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—prostate cancer	5.34e-07	5.38e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	5.33e-07	5.37e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—prostate cancer	5.33e-07	5.37e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	5.31e-07	5.35e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.3e-07	5.34e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARA—prostate cancer	5.28e-07	5.32e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	5.28e-07	5.32e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—prostate cancer	5.27e-07	5.31e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—prostate cancer	5.26e-07	5.3e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	5.26e-07	5.3e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—prostate cancer	5.26e-07	5.29e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—prostate cancer	5.25e-07	5.29e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	5.25e-07	5.29e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—prostate cancer	5.24e-07	5.28e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—prostate cancer	5.23e-07	5.27e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—prostate cancer	5.22e-07	5.26e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—prostate cancer	5.21e-07	5.25e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—prostate cancer	5.16e-07	5.2e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.15e-07	5.19e-06	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—prostate cancer	5.13e-07	5.17e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—prostate cancer	5.11e-07	5.14e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—prostate cancer	5.08e-07	5.12e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—prostate cancer	5.04e-07	5.08e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—prostate cancer	4.98e-07	5.02e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAV1—prostate cancer	4.97e-07	5.01e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—prostate cancer	4.96e-07	5e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—prostate cancer	4.95e-07	4.99e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—prostate cancer	4.94e-07	4.97e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—prostate cancer	4.92e-07	4.96e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—prostate cancer	4.89e-07	4.92e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—prostate cancer	4.87e-07	4.91e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NOS3—prostate cancer	4.87e-07	4.9e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—prostate cancer	4.86e-07	4.9e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—prostate cancer	4.78e-07	4.82e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—prostate cancer	4.78e-07	4.82e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—prostate cancer	4.75e-07	4.79e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—prostate cancer	4.71e-07	4.74e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—prostate cancer	4.67e-07	4.71e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.65e-07	4.69e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—prostate cancer	4.65e-07	4.68e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—prostate cancer	4.64e-07	4.67e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	4.63e-07	4.67e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—prostate cancer	4.58e-07	4.62e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	4.56e-07	4.59e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.56e-07	4.59e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	4.55e-07	4.58e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	4.54e-07	4.57e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.53e-07	4.56e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	4.52e-07	4.56e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—prostate cancer	4.51e-07	4.54e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.49e-07	4.53e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—prostate cancer	4.48e-07	4.52e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	4.48e-07	4.51e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—prostate cancer	4.45e-07	4.48e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—prostate cancer	4.42e-07	4.45e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—prostate cancer	4.41e-07	4.44e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—prostate cancer	4.41e-07	4.44e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—prostate cancer	4.4e-07	4.43e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—prostate cancer	4.39e-07	4.42e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—prostate cancer	4.37e-07	4.41e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—prostate cancer	4.37e-07	4.4e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—prostate cancer	4.33e-07	4.36e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—prostate cancer	4.31e-07	4.34e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—prostate cancer	4.29e-07	4.32e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INS—prostate cancer	4.28e-07	4.32e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.2e-07	4.23e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—prostate cancer	4.1e-07	4.13e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—prostate cancer	4.04e-07	4.07e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—prostate cancer	4.03e-07	4.06e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—prostate cancer	4.02e-07	4.05e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—prostate cancer	4e-07	4.03e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.98e-07	4.01e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—prostate cancer	3.96e-07	3.99e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—prostate cancer	3.88e-07	3.91e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—prostate cancer	3.8e-07	3.83e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—prostate cancer	3.79e-07	3.81e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NOS3—prostate cancer	3.76e-07	3.78e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—prostate cancer	3.73e-07	3.75e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—prostate cancer	3.72e-07	3.75e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—prostate cancer	3.72e-07	3.74e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—prostate cancer	3.71e-07	3.73e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—prostate cancer	3.7e-07	3.73e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—prostate cancer	3.69e-07	3.72e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—prostate cancer	3.66e-07	3.68e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.52e-07	3.54e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.47e-07	3.49e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.44e-07	3.46e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.43e-07	3.46e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.23e-07	3.26e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—prostate cancer	3e-07	3.02e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—prostate cancer	2.87e-07	2.89e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—prostate cancer	2.86e-07	2.88e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—prostate cancer	2.8e-07	2.82e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.74e-07	2.76e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—prostate cancer	2.64e-07	2.66e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—prostate cancer	2.24e-07	2.25e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.11e-07	2.13e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—prostate cancer	1.73e-07	1.74e-06	CbGpPWpGaD
